Новости компании
The results of the two phases of the clinical trial of Avifavir for coronavirus treatment were presented at the ...
20.11.2020
Under the Government order on financing the purchase of drugs for the treatment of outpatients with the COVID-19 ...
09.11.2020
Efficacy of favipiravir-based drugs against COVID-19 has been confirmed by clinical trials in Russia and Japan
...
24.09.2020
Moscow, September 23, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar ...
23.09.2020
Moscow, September 21, 2020 – The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar ...
21.09.2020
Moscow, August 3, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
03.08.2020
Moscow, August 3, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
03.08.2020
Research and Development institute “ChemRar” has created a unique platform for innovation drug discovery against novel ...
20.07.2020
Moscow, July 14, 2020 – Chromis, a joint venture established by the Russian Direct Investment Fund (RDIF), Russia’s ...
14.07.2020
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ChemRar Group, supported by the Russian ...
13.07.2020
RDIF and ChemRar have produced the first 100,000 courses of Avifavir
In June Avifavir was delivered across Russia’s ...
02.07.2020
Moscow, June 11, 2020 - The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and the ChemRar ...
11.06.2020